Pfizer Inc. Teams With India Brewmaster in Return to $14 Billion Insulin Market
Published: Feb 24, 2011
Bloomberg -- Biocon Ltd. founder Kiran Mazumdar- Shaw learned the intricacies of enzymes while studying how to make beer. Now Pfizer Inc., the world’s largest drugmaker, is tapping that knowledge to revive its insulin business.